Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Also read: Why Google AI Overviews are facing EU antitrust heat from publishers Isomorphic Labs was launched in 2021, growing out of DeepMind’s AI system AlphaFold. Originally designed to ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

A team from Google DeepMind and several universities introduces Aeneas, a generative (and free) AI model designed to help ...

Ancient writing is so riddled with holes, from Greek poet Sappho's fragmentary poetry to entire missing stories from famed ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Google's AI battle plan. A British-born cognitive neuroscience Ph.D., Hassabis cofounded DeepMind in 2010 with the goal of one day creating a general-purpose artificial intelligence.

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...